 | Up a level |
Schoepfer, A; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2008). Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflammatory bowel diseases, 14(1), pp. 32-39. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20275
Schoepfer, A M; Schaffer, T; Seibold-Schmid, B; Müller, S; Seibold, F (2008). Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterology and motility, 20(10), pp. 1110-8. Oxford: Blackwell Science 10.1111/j.1365-2982.2008.01166.x
Schaffer, T; Mueller, S; Flogerzi, B; Seibold-Schmid, B; Schoepfer, A; Seibold, F (2007). Anti-Saccharomyces cerevisiae antibodies in Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflammatory bowel diseases, 13(11), pp. 1339-1346. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20228
Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Mueller, S; Kun, JF (2007). Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: A family study. Inflammatory bowel diseases, 13(9), pp. 1077-1082. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20156
Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Mueller, S; Kun, JF (2007). Deficiency for mannan-binding lectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives. Gut, 56(1), p. 152. London: BMJ Publishing Group 10.1136/gut.2006.110007
Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Discriminating IBD from IBS: a Comparative Evaluation of the Test Performance of Fecal Markers and IBD Antibodies. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 5S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated antibodies against Flagellin support the concept of low-grade Mucosal Inflammation in Irritable Bowel Syndrome. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 4S. Basel: EMH Editores Medicorum Helveticorum
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated Antibodies against Flagellin support the Concept of Low Grade Mucosal Inflammation in Irritable Bowel Syndrome. Gastroenterology Philadelphia, Pa.: Elsevier
Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Biomarkers for Discrimination of IBD versus IBS: Accuracy of Fecal Leucocyte Markers is improved when combined with IBD Antibody Panels. Journal of Crohn's & Colitis(1), AP13. Amsterdam: Elsevier
Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2006). Antibodies to Flagellin: Clinical significance in Inflammatory bowel disease. American journal of gastroenterology(1101), A1158. New York, N.Y.: Nature
